| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.34 | 0.04 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.33 | 0.002 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.22 | 8e-08 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.08 |